Search Results | Neuronal Signaling

1-30 of 30

Sort by

Sort Order Select

Articles

Maternal immune activation and role of placenta in the prenatal programming of neurodevelopmental disorders

Rebecca M. Woods, Jarred M. Lorusso, Jennifer Fletcher, Heidi ElTaher, Francesca McEwan, Isabella Harris, Hager M. Kowash, Stephen W. D'Souza, Michael Harte, Reinmar Hager, Jocelyn D. Glazier

Neuronal Signal (2023) 7 (2): NS20220064.

DOI: https://doi.org/10.1042/NS20220064

Published: 31 May 2023

View article titled, Maternal immune activation and role of placenta in the prenatal programming of neurodevelopmental disorders

Articles

Amyloid-β in Alzheimer’s disease – front and centre after all?

Caroline Weglinski, Alexander Jeans

Neuronal Signal (2023) 7 (1): NS20220086.

DOI: https://doi.org/10.1042/NS20220086

Published: 06 January 2023

View article titled, Amyloid-β in Alzheimer’s disease – front and centre after all?

Articles

The role of thalamic group II mGlu receptors in health and disease

In Collection

Celebrating 125 years of the Synapse

Caroline S. Copeland, Thomas E. Salt

Neuronal Signal (2022) 6 (4): NS20210058.

DOI: https://doi.org/10.1042/NS20210058

Published: 15 November 2022

View article titled, The role of thalamic group II mGlu receptors in health and disease

Articles

Neuroligins in neurodevelopmental conditions: how mouse models of de novo mutations can help us link synaptic function to social behavior

In Collection

Emerging technologies for research models of human neuronal disorders in vivo and in vitro , Celebrating 125 years of the Synapse

Tobias T. Pohl, Hanna Hörnberg

Neuronal Signal (2022) 6 (2): NS20210030.

DOI: https://doi.org/10.1042/NS20210030

Published: 10 May 2022

View article titled, Neuroligins in neurodevelopmental conditions: how mouse models of de novo mutations can help us link synaptic function to social behavior

Articles

Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes

Greg Maguire, Christy Eubanks, George Ayoub

Neuronal Signal (2022) 6 (1): NS20210038.

DOI: https://doi.org/10.1042/NS20210038

Published: 16 February 2022

View article titled, Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes

Articles

Cholinergic blockade of neuroinflammation: from tissue to RNA regulators

Tamara Zorbaz, Nimrod Madrer, Hermona Soreq

Neuronal Signal (2022) 6 (1): NS20210035.

DOI: https://doi.org/10.1042/NS20210035

Published: 11 February 2022

View article titled, Cholinergic blockade of neuroinflammation: from tissue to RNA regulators

Articles

Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research

In Collection

Emerging technologies for research models of human neuronal disorders in vivo and in vitro

Joana Lama, Yazead Buhidma, Edward J.R. Fletcher, Susan Duty

Neuronal Signal (2021) 5 (4): NS20210026.

DOI: https://doi.org/10.1042/NS20210026

Published: 08 December 2021

View article titled, Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research

Articles

Molecular mechanisms of action of stimulant novel psychoactive substances that target the high-affinity transporter for dopamine

Michelle A. Sahai, Jolanta Opacka-Juffry

Neuronal Signal (2021) 5 (4): NS20210006.

DOI: https://doi.org/10.1042/NS20210006

Published: 17 November 2021

View article titled, Molecular mechanisms of action of stimulant novel psychoactive substances that target the high-affinity transporter for dopamine

Articles

3D hydrogel models of the neurovascular unit to investigate blood–brain barrier dysfunction

In Collection

Emerging technologies for research models of human neuronal disorders in vivo and in vitro

Geoffrey Potjewyd, Katherine A.B. Kellett, Nigel M. Hooper

Neuronal Signal (2021) 5 (4): NS20210027.

DOI: https://doi.org/10.1042/NS20210027

Published: 09 November 2021

View article titled, 3D hydrogel models of the neurovascular unit to investigate blood–brain barrier dysfunction

Articles

Super-resolution imaging to reveal the nanostructure of tripartite synapses

Natalija Aleksejenko, Janosch P. Heller

Neuronal Signal (2021) 5 (4): NS20210003.

DOI: https://doi.org/10.1042/NS20210003

Published: 14 October 2021

View article titled, Super-resolution imaging to reveal the nanostructure of tripartite synapses

Articles

Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?

Gema Lordén, Alexandra C. Newton

Neuronal Signal (2021) 5 (4): NS20210036.

DOI: https://doi.org/10.1042/NS20210036

Published: 08 October 2021

View article titled, Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?

Articles

Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions

David R. Lynch, Garrett Farmer

Neuronal Signal (2021) 5 (2): NS20200093.

DOI: https://doi.org/10.1042/NS20200093

Published: 17 May 2021

View article titled, Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions

Articles

The life cycle of voltage-gated Ca 2+ channels in neurons: an update on the trafficking of neuronal calcium channels

Laurent Ferron, Saloni Koshti, Gerald W. Zamponi

Neuronal Signal (2021) 5 (1): NS20200095.

DOI: https://doi.org/10.1042/NS20200095

Published: 23 February 2021

View article titled, The life cycle of voltage-gated Ca 2+ channels in neurons: an update on the trafficking of neuronal calcium channels

Articles

Exercise alters LPS-induced glial activation in the mouse brain

Bibiana C. Mota, Áine M. Kelly

Neuronal Signal (2020) 4 (4): NS20200003.

DOI: https://doi.org/10.1042/NS20200003

Published: 02 December 2020

View article titled, Exercise alters LPS-induced glial activation in the mouse brain

Articles

New developments in Huntington’s disease and other triplet repeat diseases: DNA repair turns to the dark side

Robert S. Lahue

Neuronal Signal (2020) 4 (4): NS20200010.

DOI: https://doi.org/10.1042/NS20200010

Published: 16 November 2020

View article titled, New developments in Huntington’s disease and other triplet repeat diseases: DNA repair turns to the dark side

Articles

The class II histone deacetylases as therapeutic targets for Parkinson’s disease

Martina Mazzocchi, Louise M Collins, Aideen M. Sullivan, Gerard W. O'Keeffe

Neuronal Signal (2020) 4 (2): NS20200001.

DOI: https://doi.org/10.1042/NS20200001

Published: 09 June 2020

View article titled, The class II histone deacetylases as therapeutic targets for Parkinson’s disease

Articles

Oxidized cholesterol species as signaling molecules in the brain: diabetes and Alzheimer’s disease

Thaddeus K. Weigel, Joshua A. Kulas, Heather A. Ferris

Neuronal Signal (2019) 3 (4): NS20190068.

DOI: https://doi.org/10.1042/NS20190068

Published: 28 November 2019

View article titled, Oxidized cholesterol species as signaling molecules in the brain: diabetes and Alzheimer’s disease

Articles

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions

Holly C. Hunsberger, Priyanka D. Pinky, Warren Smith, Vishnu Suppiramaniam, Miranda N. Reed

Neuronal Signal (2019) 3 (2): NS20180203.

DOI: https://doi.org/10.1042/NS20180203

Published: 18 April 2019

View article titled, The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions

Articles

Modulation of CRMP2 via ( S )-Lacosamide shows therapeutic promise but is ultimately ineffective in a mouse model of CLN6-Batten disease

Katherine A. White, Jacob T. Cain, Helen Magee, Seul Ki Yeon, Ki Duk Park, Rajesh Khanna, Jill M. Weimer

Neuronal Signal (2019) 3 (2): NS20190001.

DOI: https://doi.org/10.1042/NS20190001

Published: 08 April 2019

View article titled, Modulation of CRMP2 via ( S )-Lacosamide shows therapeutic promise but is ultimately ineffective in a mouse model of CLN6-Batten disease

Articles

Mitochondrial quality control and neurodegenerative diseases

Fei Gao, Jianmin Zhang

Neuronal Signal (2018) 2 (4): NS20180062.

DOI: https://doi.org/10.1042/NS20180062

Published: 03 December 2018

View article titled, Mitochondrial quality control and neurodegenerative diseases

Articles

Mitochondrial calcium signalling and neurodegenerative diseases

Elena Britti, Fabien Delaspre, Jordi Tamarit, Joaquim Ros

Neuronal Signal (2018) 2 (4): NS20180061.

DOI: https://doi.org/10.1042/NS20180061

Published: 16 November 2018

View article titled, Mitochondrial calcium signalling and neurodegenerative diseases

Articles

Preeclamptic placentae release factors that damage neurons: implications for foetal programming of disease

Hannah Scott, Tom J. Phillips, Greer C. Stuart, Mark F. Rogers, Bruno R. Steinkraus, Simon Grant, C. Patrick Case

Neuronal Signal (2018) 2 (4): NS20180139.

DOI: https://doi.org/10.1042/NS20180139

Published: 12 October 2018

View article titled, Preeclamptic placentae release factors that damage neurons: implications for foetal programming of disease

Includes: Supplementary data

Articles

Physiological and pathological functions of LRRK2: implications from substrate proteins

In Collection

Protein structure and function

Miho Araki, Genta Ito, Taisuke Tomita

Neuronal Signal (2018) 2 (4): NS20180005.

DOI: https://doi.org/10.1042/NS20180005

Published: 10 October 2018

View article titled, Physiological and pathological functions of LRRK2: implications from substrate proteins

Articles

A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome

Sarah E. Hurst, Erika Liktor-Busa, Aubin Moutal, Sara Parker, Sydney Rice, Szabolcs Szelinger, Grant Senner, Michael F. Hammer, Laurel Johnstone, Keri Ramsey, Vinodh Narayanan, Samantha Perez-Miller, May Khanna, Heather Dahlin, Karen Lewis, David Craig, Edith H. Wang, Rajesh Khanna, Mark A. Nelson

Neuronal Signal (2018) 2 (3): NS20180141.

DOI: https://doi.org/10.1042/NS20180141

Published: 16 July 2018

View article titled, A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome

Includes: Supplementary data

Articles

A role for viral infections in Parkinson’s etiology?

Laura K. Olsen, Eilis Dowd, Declan P. McKernan

Neuronal Signal (2018) 2 (2): NS20170166.

DOI: https://doi.org/10.1042/NS20170166

Published: 16 April 2018

View article titled, A role for viral infections in Parkinson’s etiology?

Articles

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease

Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe

Neuronal Signal (2018) 2 (1): NS20170181.

DOI: https://doi.org/10.1042/NS20170181

Published: 26 January 2018

View article titled, Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease

Articles

SUMOylation and calcium signalling: potential roles in the brain and beyond

Leticia Coelho-Silva, Gary J. Stephens, Helena Cimarosti

Neuronal Signal (2017) 1 (3): NS20160010.

DOI: https://doi.org/10.1042/NS20160010

Published: 19 July 2017

View article titled, SUMOylation and calcium signalling: potential roles in the brain and beyond

Articles

Conventional protein kinase C in the brain: 40 years later

Julia A. Callender, Alexandra C. Newton

Neuronal Signal (2017) 1 (2): NS20160005.

DOI: https://doi.org/10.1042/NS20160005

Published: 10 April 2017

View article titled, Conventional protein kinase C in the brain: 40 years later

Articles

AMPK: keeping the (power)house in order?

Claire Thornton

Neuronal Signal (2017) 1 (2): NS20160020.

DOI: https://doi.org/10.1042/NS20160020

Published: 24 March 2017

View article titled, AMPK: keeping the (power)house in order?

Articles

Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies

Francisco Zafra, Ignacio Ibáñez, Cecilio Giménez

Neuronal Signal (2017) 1 (1): NS20160009.

DOI: https://doi.org/10.1042/NS20160009

Published: 22 December 2016

View article titled, Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies

NARROW

Maternal immune activation and role of placenta in the prenatal programming of neurodevelopmental disorders

Amyloid-β in Alzheimer’s disease – front and centre after all?

The role of thalamic group II mGlu receptors in health and disease

Neuroligins in neurodevelopmental conditions: how mouse models of de novo mutations can help us link synaptic function to social behavior

Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes

Cholinergic blockade of neuroinflammation: from tissue to RNA regulators

Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research

Molecular mechanisms of action of stimulant novel psychoactive substances that target the high-affinity transporter for dopamine

3D hydrogel models of the neurovascular unit to investigate blood–brain barrier dysfunction

Super-resolution imaging to reveal the nanostructure of tripartite synapses

Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?

Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions

The life cycle of voltage-gated Ca 2+ channels in neurons: an update on the trafficking of neuronal calcium channels

Exercise alters LPS-induced glial activation in the mouse brain

New developments in Huntington’s disease and other triplet repeat diseases: DNA repair turns to the dark side

The class II histone deacetylases as therapeutic targets for Parkinson’s disease

Oxidized cholesterol species as signaling molecules in the brain: diabetes and Alzheimer’s disease

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions

Modulation of CRMP2 via ( S )-Lacosamide shows therapeutic promise but is ultimately ineffective in a mouse model of CLN6-Batten disease

Mitochondrial quality control and neurodegenerative diseases

Mitochondrial calcium signalling and neurodegenerative diseases

Preeclamptic placentae release factors that damage neurons: implications for foetal programming of disease

Physiological and pathological functions of LRRK2: implications from substrate proteins

A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome

A role for viral infections in Parkinson’s etiology?

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease

SUMOylation and calcium signalling: potential roles in the brain and beyond

Conventional protein kinase C in the brain: 40 years later

AMPK: keeping the (power)house in order?

Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies

Email alerts

CONNECT

EXPLORE

Email alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only